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There is a strong relation between socioeconomic position and health outcomes, although the mechanisms are
poorly understood. The authors used data from 1,503 California participants in the 1998–1999 Sacramento Area
Latino Study on Aging aged 60–100 years to ask whether socioeconomic position is related to immune function as
measured by the body’s ability to keep latent herpesvirus antibody levels in a quiescent state. Individuals with lower
educational levels had significantly higher levels of immunoglobulin G antibodies to cytomegalovirus and herpes
simplex virus type 1. The odds ratio for being in a higher tertile of cytomegalovirus antibodies was 1.54 (95%
confidence interval: 1.18, 2.01) for those in the lowest educational group, and the odds ratio for being in a higher
tertile of herpes simplex virus type 1 was 1.63 (95% confidence interval: 1.25, 2.13). The relation between edu-
cation and cytomegalovirus and herpes simplex virus type 1 antibody levels remained strong after controlling for
baseline health conditions, smoking status, and body mass index. This is the first study known to show a relation
between socioeconomic position and immune response to latent infection. It provides suggestive evidence that
modulation of the immune system via latent infections may play a role in the observed associations between
socioeconomic position and disease.
aging; cytomegalovirus; herpesvirus 1, human; Hispanic Americans; immunity; social class; socioeconomic
factors
Abbreviations: CMV, cytomegalovirus; CRP, C-reactive protein; HSV-1, herpes simplex virus type 1; SALSA, Sacramento Area
Latino Study on Aging.
Although the relation between socioeconomic position
and health outcomes is well established in many contexts,
the physical mechanisms linking socioeconomic position
and health are poorly understood. Plausible explanations
such as health behaviors and access to health care have
failed to adequately clarify the gradient (1). Increasingly,
social scientists are incorporating biomarkers into research
to better identify and test mechanisms by which socioeco-
nomic position can get ‘‘under the skin’’ and damage an
individual’s physiological well-being (2).
There is evidence that individuals with lower educational
levels and incomes are more likely to experience both
chronic and acute stressors in their lives through their phys-
ical, financial/occupational, and sociocultural environments
(3, 4). This stress, in turn, is thought to impact health out-
comes via sustained activation of stress-related autonomic
and neuroendocrine responses and impaired immunity.
Chronically elevated cortisol levels is one commonly sug-
gested mechanism through which low socioeconomic posi-
tion may damage health. Recent work linking cortisol to
socioeconomic position has produced mixed results, provid-
ing little direct evidence that stress-related biologic altera-
tions explain the relation between socioeconomic position
and health (2, 5–9).
Chronic inflammation has also been suggested as a poten-
tial mechanism through which psychosocial stress may
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affect disease, and several studies have linked exposure to
stressors and symptoms of depression with increased im-
mune production of proinflammatory molecules (10–12).
Two recent studies suggest that stress may up-regulate
C-reactive protein (CRP) production (13, 14). Moreover,
several studies have documented a relation between socio-
economic position and levels of CRP (12, 15–18), suggest-
ing that inflammatory pathways may link socioeconomic
position and health. Some of these studies show that a sub-
stantial proportion of the relation between socioeconomic
position and CRP can be accounted for by associations with
behavioral and health variables such as smoking and obesity
(15–18). The significance of stress relative to the behavioral
explanation is yet unclear.
Several issues must be considered when using cortisol
and CRP to test pathways through which lower socioeco-
nomic position can harm health. Cortisol follows a circadian
rhythm, which results in substantial within-individual varia-
tion in the measurement of this marker (19–21). This vari-
ability may make cortisol a less practical marker for testing
socioeconomic position–stress pathways in population-level
research and may account for inconsistencies in these asso-
ciations. CRP shows less intra- and interindividual variability
than does cortisol. However, CRP’s strong correlation with
important health-related behaviors may confound the direct
relation between socioeconomic position, stress, and CRP.
A promising alternative to examining neuroendocrine
markers such as cortisol or inflammatory markers such as
CRP in the socioeconomic position–stress relation is to mea-
sure a surrogate indicator of immune system functioning,
such as the body’s ability to keep latent herpesvirus antibody
levels in a quiescent state. Critical reviews of the psychoneu-
roimmunology literature support a strong and consistent re-
lation between stress and increased antibody response to
herpesviruses (22). Specifically, increases in herpesvirus an-
tibody titers have been linked to academic stress in medical
students and military cadets (23), caregiving for a family
member with Alzheimer’s disease (24), involvement in
a poor-quality marriage (22), anticipation of space flight by
astronauts (25), traumatic life events (26), and psychological
traits of loneliness and anxiety (27). Evidence of reactivation
from other causes includes cases of immunosuppression such
as human immunodeficiency virus infection, organ trans-
plants, and chemotherapy (28–30).
Exposure to herpesviruses such as cytomegalovirus
(CMV) and herpes simplex virus type 1 (HSV-1) is nearly
ubiquitous in early life (31). Although infection with CMV
and HSV-1 often passes undiagnosed because of the asymp-
tomatic properties of these viruses, they persist in the in-
fected host for life, with an increasing risk of subclinical
reactivation during old age (32, 33). Stress-related changes
in cellular immunity can facilitate subclinical herpesvirus
reactivation. Levels of immunoglobulin G antibodies to
CMV and HSV-1 have therefore been used as an indirect
measure of alterations in immune function in response to
stress (24, 26).
Recent work suggests that stress-induced viral reactiva-
tion of CMV may reduce the capacity of the immune system
to respond to other challenges (34). CMV infection has even
been called the ‘‘driving force’’ behind age-related altera-
tions to the T-cell immune system (32). Both CMV and
HSV-1 have been linked to inflammatory processes, cardio-
vascular disease, cognitive outcomes, and Alzheimer’s dis-
ease (35–38). Given this evidence, CMVand HSV-1 provide
a unique opportunity to examine a specific immunologic
pathway through which socioeconomic position may affect
chronic health conditions.
There are clear age, gender, race/ethnicity, and socioeco-
nomic gradients associated with HSV-1 and CMV seropos-
itivity status (31, 39). Ethnic differences in seropositivity to
HSV-1 and CMV were found in the Third National Health
and Nutrition Examination Survey, where 85.1 percent of
Mexican Americans were found to have antibodies to HSV-1,
compared with 74.1 percent of non-Hispanic Blacks and
64.7 percent of non-Hispanic Whites (39). Age-adjusted
seroprevalence rates for CMV were 81.7 percent for Mexican
Americans, 75.8 percent for non-Hispanic Blacks, and 51.2
percent for non-Hispanic Whites (31).
Despite the evidence on seropositivity, it is unclear
whether social gradients model immune response among
infected individuals. There are no studies of which we are
aware that have examined the existence of social disparities
in immune response to latent infections in aging US popu-
lations. This is an important question, since differentials in
antibody response may provide a biologic indicator of the
socioeconomic gradient in cell-mediated immunity. This
study examined the relation between socioeconomic posi-
tion, as measured by level of education, and serum levels of
antibodies to persistent CMV and HSV-1 infection. We also
compared the herpesvirus results with models testing the
associations between education and cortisol and education
and CRP, two biomarkers frequently implicated as media-
tors of the socioeconomic position–health gradient.
MATERIALS AND METHODS
Study population
Participants were drawn from the Sacramento Area Latino
Study on Aging (SALSA), an ongoing prospective cohort
study of community-dwelling Mexican Americans aged
60–100 years at baseline in 1998–1999. A subsample of
participants (n ¼ 1,561) from the SALSA cohort (N ¼
1,789) for whom blood samples for CMV, HSV-1, CRP,
and cortisol were available were included in the analyses.
Individuals for whom blood samples were missing were
more likely to be in the lowest education (39.1 percent vs.
31.2 percent, p ¼ 0.0019) and lowest income (53.1 percent
vs. 43.6 percent, p < 0.0001) categories but did not differ in
age or sex. Fifty-eight observations for which data on de-
pendent variables or covariates were missing were dropped,
leaving 1,503 observations. Details of the SALSA study
have been discussed previously, and all analyses were ap-
proved by the Institutional Review Board at the University
of Michigan and the University of California, Davis (40).
Measures
Baseline data for SALSA began to be collected in 1998
with a 2-hour interview at the participant’s home. Information
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on years of education, household income, medical history,
and duration and date of diagnoses for 35 health conditions
was gathered. Clinical evaluations were used to measure
blood pressure, weight/height, and waist/hip ratios. Partic-
ipants were asked to fast on the assigned day of the blood
draw. A trained phlebotomist went to the home of the par-
ticipant to collect a single fasting morning blood sample,
which was processed within 4 hours of collection. Result-
ing serum and plasma samples were stored at 70C until
analysis.
A commercially available enzyme-linked immunoadsorb-
ent assay immunoglobulin G detection system (Wampole
Laboratories, Princeton, New Jersey) was used to analyze
the level (expressed as optical density units) of immuno-
globulin G antibody to HSV-1 and CMV in frozen serum
samples. Each 96-well enzyme-linked immunoadsorbent
assay kit contained controls and internal calibrations. Fol-
lowing manufacturer instructions, we assessed samples for
the level of immunoglobulin G antibody signal as expressed
by the mean optical density value. The sensitivity and spec-
ificity of the assay for HSV-1 are reported to be 97.1 percent
and 96.8 percent, respectively; for CMV, the sensitivity and
specificity are reported to be 99.0 percent and 94.0 percent,
respectively.
A commercially available in vitro diagnostic test was
used for the quantitative determination of CRP (CRP Ultra
Wide Range Reagent Kit latex-enhanced immunoassay,
Equal Diagnostics, Exton, Pennsylvania). The manufac-
turer’s instructions were followed, and CRP levels were de-
termined by an automated analyzer using a prepared
calibration curve. With the highly sensitive method, the
kit provides a range of measurable CRP from 0.05 mg/liter
to 80.0 mg/liter.
Serum cortisol from the single fasting morning blood
sample was measured by using an automated chemilumines-
cence assay (ACS:180; Bayer HealthCare, Leverkusen, Ger-
many). The manufacturer’s instructions were followed, and
total cortisol levels were determined by an automated ana-
lyzer using a standardized calibration curve. The assay
measures serum cortisol concentrations up to 75 lg/dl, with
a minimum detectable concentration of 0.20 lg/dl.
Continuous levels of antibody to CMV and HSV-1 were
included in regression models and were divided into tertiles
for ordered logit models, as were cortisol and CRP (CRP
was log-transformed because of skewness). A modified
Charlson index was used to control for chronic health con-
ditions. The Charlson index uses a weighting system for
each condition category based on the adjusted risk of 1-year
mortality (41). A higher score reflects a more severe burden
of comorbidity. Weights were assigned for having myocar-
dial infarction, congestive heart failure, stroke, dementia,
liver disease, diabetes, renal disease, any malignancy, and
leukemia or lymphoma, and points for each condition were
summed to create the final score, as previously described
(41). Information on current infections and some immune-
related conditions such as rheumatoid arthritis and human
immunodeficiency virus was not available. To assess
whether the effects of these immune-related conditions or
current infections influenced our results, we created two
medication variables to represent whether an individual was
taking any drugs near the time of the blood sample used as
treatments for 1) concurrent infection (i.e., antibiotics, cold
medicines, antivirals, antiretrovirals) or 2) autoimmune disor-
ders (i.e., corticosteroids, immunologic agents, immunomod-
ulators, antiarthritics).
Statistical analyses
Linear regression models were used to test the relation
between continuous years of education and yearly income
with continuous CMV, HSV-1, CRP, and cortisol values.
Education was examined continuously and was also divided
into three categories based on the distribution of education
in this sample (0–3 years, 4–11 years, 12 years). Gross
monthly household income was measured in three categories
(<$1,000, $1,000–2,000, >$2,000).
Ordered logit models were used to test the relation be-
tween categorical levels of education and income with ter-
tile values of CMV, HSV-1, CRP, and cortisol. Other
covariates included in each model were age, sex, whether
the respondent was born in the United States, household
size, Charlson comorbidity index, smoking status (never,
former, current), and an indicator for a body mass index
of >30 kg/m2. The autoimmune medication variable was
not significantly associated with any of the biomarkers. Al-
though use of infection medication was associated with
higher CRP, its inclusion did not alter the relation between
HSV-1 and CRP. Medication variables were thus excluded
from final models.
RESULTS
Demographics and other characteristics of the SALSA
sample are shown in table 1. When the clinical cutpoints
designated by the enzyme-linked immunoadsorbent assay
test kits were used, 97.0 percent of the study subjects
showed signs of prior infection with CMV, and 98 percent
showed prior infection with HSV-1. The biomarkers showed
some associations with one another; positive correlations
were found between CMV and Ln(CRP) (r ¼ 0.139, p <
0.001) and Ln(CRP) and cortisol (r¼ 0.103, p 0.001), and
between CMV and HSV-1 (r ¼ 0.139, p < 0.001). Cortisol
was not significantly associated with CMV or socioeco-
nomic position, and Ln(CRP) was not associated with
HSV-1.
Figure 1 shows the age-adjusted associations between
education and antibody levels of CMV and HSV-1 based
on linear regression models. A strong and significant rela-
tion between more years of education and lower antibody
levels to CMV(r ¼ 0.14, p < 0.001) and HSV-1 (r ¼
0.14, p < 0.001) was observed. Although monthly house-
hold income was a significant predictor of CMV and HSV-1
in models without education (data not shown), it was not
significant after including education and was therefore ex-
cluded from final models. Figure 2 shows the age-adjusted
associations of education with Ln(CRP) and cortisol based
on linear regression models. A much weaker relation between
education and these biomarkers was observed, and the effect
estimates were not statistically significant (Ln(CRP): r ¼
0.02, p ¼ 0.46; cortisol: r ¼ 0.01, p ¼ 0.69). Income
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was not associated with CRP or cortisol by itself or jointly
with education and was thus excluded from final models.
Table 2 shows results for the ordered logit models of
CMV, HSV-1, and level of education. Results were similar
for both markers, whereby individuals with less education
showed significantly higher levels of antibody. For individ-
uals with 0–3 years of education, the odds were 1.54 (95
percent confidence interval: 1.18, 2.01) and 1.63 (95 percent
confidence interval: 1.25, 2.13) of being in a higher tertile of
antibody levels to CMV and HSV-1, respectively, compared
with individuals with 12 or more years of education. In this
table, model 2 controls for demographic variables and
health characteristics of the individuals that might affect
antibody levels. Although smoking was marginally associ-
ated with higher levels of CMV and obesity was signifi-
cantly associated with lower levels of HSV-1, inclusion of
these health/behavior covariates did not diminish the strength
of the relation between level of education and levels of anti-
bodies to CMV and HSV-1.
Models assessing the relation between education and
CRP and cortisol are shown in table 3. Although there was
no significant relation between level of education and CRP
or cortisol, there was a strong relation between almost all of
our baseline health/behavior covariates and these markers.
The modified Charlson comorbidity index, smoking, and
obesity were all associated with greater odds of being in
a higher tertile of CRP. The Charlson index and being a for-
mer smoker were both associated with greater odds of being
in a higher tertile of cortisol, whereas obesity was associated
with reduced odds of being in a higher tertile of cortisol.
DISCUSSION
Our study demonstrated a significant relation between
lower levels of education and increased CMV and HSV-1
antibody levels among Mexican Americans in the United
States. This study represents an important new direction
for researchers investigating the biophysical mechanisms
connecting socioeconomic position and health outcomes.
The finding of an association between CMV and HSV-1
immunoglobulin G antibody levels and education, which
remained after adjustment for existing health conditions
and health behaviors, suggests that modulation of the im-
mune system, possibly due to stress, may be a pathway
through which socioeconomic position affects future health
outcomes.
Our results are consistent with previous research linking
low socioeconomic position and susceptibility to upper re-
spiratory infections in humans (42), suggesting that psycho-
logical stress associated with low socioeconomic position
can down-regulate various aspects of cellular immune re-
sponse. In contrast to these previous studies, measuring the
relation between social status and primary infection of rhi-
noviruses, our study examined lifelong latent infections be-
lieved to play important roles in chronic diseases of aging
(35–38).
Numerous studies have documented an inverse associa-
tion between socioeconomic position and several chronic
inflammation–associated conditions such as cardiovascular
disease and dementia (43–45). The biologic pathways that
mediate these associations have not been thoroughly char-
acterized. The social gradient in cardiovascular disease per-
sists even after adjustment for health behaviors and many
clinical indicators, suggesting that other processes may be
involved (46, 47). It is possible that immune response to
latent infection may explain some of the socioeconomic
gradients in cardiovascular disease and possibly other
inflammatory-associated conditions.
Even though our findings are not consistent with several
studies reporting a significant relation between CRP and
socioeconomic position, they are consistent with findings
that health-related behaviors such as smoking and obesity
are strongly related to CRP and may moderate the relation
with socioeconomic position in many contexts. Our findings
regarding cortisol add to growing evidence that different meas-
ures of cortisol are not consistently related to socioeconomic
TABLE 1. Demographic and other characteristics of the
Sacramento Area Latino Study on Aging baseline sample





Age at baseline (years) 70.4 (7.0)
Female gender 58.1
Years of education (no.) 7.5 (5.4)








Place of birth Mexico or other
Latin-American country 48.70
Household size (no. of persons) 2.7 (1.7)
CMV* immunoglobulin G antibody
level (optical density units) 4.98 (2.03)
HSV-1* immunoglobulin G antibody
level (optical density units) 6.55 (2.23)










Body mass index >30 kg/m2 41
* CMV, cytomegalovirus; HSV-1, herpes simplex virus type 1;
CRP, C-reactive protein.
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position across surveys and thus may not be a robust marker
for examining the relation between socioeconomic position,
stress, and health outcomes. Studies have shown that gluco-
corticoids can enhance HSV-1 and CMV infection in vitro
and in animal models (48, 49). However, our results showed
no correlation between these infections and a single mea-
surement of cortisol. Infections with HSV-1 and CMV have
been implicated as stimulators of CRP production (50).
FIGURE 1. Association between education and antibody levels, Sacramento Area Latino Study on Aging, California, 1998–1999. Shown are the
fitted values of separate regressions of A) cytomegalovirus (CMV) and B) herpes simplex virus type 1 (HSV-1) immunoglobulin G (IgG) antibody
levels as optical density units on years of education, adjusted for age. Dotted lines, 95% confidence intervals.
FIGURE 2. Association between education and C-reactive protein (CRP) and cortisol levels, Sacramento Area Latino Study on Aging, California,
1998–1999. Shown are the fitted values of separate regressions of A) the natural log of CRP and B) serum cortisol on years of education, adjusted
for age. Dotted lines, 95% confidence intervals.
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Only CMV was significantly correlated with CRP in our
data, and inclusion of CRP did not moderate the relation
between CMV and education. This finding suggests that the
pathways between education and the biomarkers examined
in this study may be independent.
Our results regarding the socioeconomic gradient in an-
tibody response support and expand upon results from
a nationally representative sample showing that income
is associated with CMV seropositivity and that both in-
come and education are associated with HSV-1 seroposi-
tivity. The rates of seroprevalence in our study were
comparable to those for Mexican Americans aged 60 years
or older in the Third National Health and Nutrition Exam-
ination Survey, where prevalence has been reported to be
97.2 percent for HSV-1 and 91.3 percent for CMV
(31, 39).
The immunologic tests generally used to categorize sero-
positivity to HSV-1 and CMV are based on predesignated
clinical cutoffs. We chose to include all subjects, regardless
of clinical cutoffs, since analyses with or without the few
subjects who were seronegative for CMV (3 percent) or
HSV-1 (2 percent) led to the same results. The decision to
include all subjects in our final analyses was also based on
the high prevalence of these infections in our study popula-
tion and the concern that clinically appointed cutoffs may be
overly stringent (51). We think it is important in the future to
not focus solely on seropositivity cutoffs, since continuous
levels of immunoglobulin G antibody may provide informa-
tion on intensity of exposure, subclinical reactivation, and
immune response to these highly prevalent infections.
Although antibody response may provide insight into a so-
cial gradient in immune response, there are potential limi-
tations associated with the use of viral antibodies as
a marker. For example, increased levels of immunoglobulin
G–specific antibodies may indicate recent primary infec-
tion. However, this possibility was unlikely in our study
population since both initial infection as well as reinfection
with HSV-1 and CMV commonly occur at young ages
TABLE 2. Ordered logit models*: odds ratios for being in a higher tertile of CMVy and HSV-1y by education, Sacramento Area Latino
Study on Aging, California, 1998–1999
Covariate
CMV HSV-1





















Education: 12 years Reference Reference Reference Reference
Education: 4–11 years 1.22 0.96, 1.54 1.22 0.96, 1.55 1.23 0.97, 1.55 1.22 0.96, 1.54
Education: 0–3 years 1.54 1.18, 2.01 1.51 1.15, 1.97 1.63 1.25, 2.13 1.66 1.27, 2.19
Charlson index 1.06 0.98, 1.15 1.02 0.95, 1.11
Former smoker 1.22 0.99, 1.52 1.05 0.85, 1.30
Current smoker 1.23 0.90, 1.71 0.97 0.71, 1.34
Body mass index >30 kg/m2 0.95 0.78, 1.15 0.80 0.66, 0.97
* All models were adjusted for age, sex, household size, and place of birth.
yCMV, cytomegalovirus; HSV-1, herpes simplex virus.
TABLE 3. Ordered logit models*: odds ratios for being in a higher tertile of CRPy and serum cortisol by education, Sacramento Area
Latino Study on Aging, California, 1998–1999
Covariate
CRP Cortisol





















Education: 12 years Reference Reference Reference Reference
Education: 4–11 years 1.05 0.83, 1.32 0.98 0.77, 1.24 1.06 0.82, 1.37 1.02 0.79, 1.33
Education: 0–3 years 1.31 0.99, 1.71 1.19 0.90, 1.57 1.05 0.77, 1.42 1.02 0.75, 1.39
Charlson index 1.23 1.13, 1.33 1.17 1.06, 1.28
Former smoker 1.30 1.04, 1.61 1.28 1.00, 1.62
Current smoker 2.02 1.45, 2.82 1.08 0.75, 1.57
Body mass index >30 kg/m2 1.86 1.53, 2.27 0.79 0.63, 0.98
* All models were adjusted for age, sex, household size, and place of birth.
yCRP, C-reactive protein.
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(52, 53). Studies conducted of elderly in nursing homes have
documented little to no transmission of CMV (54). We also
found no association between household size or number of
children in the household and CMVor HSV-1 antibody levels,
which are generally important surrogate markers of infection
exposure and increased likelihood of transmission. Popula-
tion-based studies have suggested that sexual transmission is
a risk factor for reexposure to CMV and HSV-1 (31, 39).
Given that our population comprised individuals aged 60
years or older, it is unlikely that sexual behaviors explain
the patterns of socioeconomic position and antibody response
to infection in our study population. It is also possible that
higher antibody response may indicate that the initial infec-
tion experienced by individuals was stronger or that they have
been repeatedly exposed throughout life. If this is the case,
then high antibody levels may be a marker for early-life or
cumulative socioeconomic variation in level of exposure to
these infections.
Several smaller studies have reported heightened immu-
noglobulin G antibody response to CMV and other herpes-
viruses in older subjects compared with their younger
counterparts (55–57). One study reported a combination of
heightened serum CMV antibody levels and CMV DNA
shedding in the urine but not in the blood, suggesting that
aging subjects with high immunoglobulin G antibody levels
may be experiencing frequent subclinical CMV reactivation
(58). Given that shedding of CMV DNA has been shown to
accompany high immunoglobulin G response in the aged, it
is plausible that the high immunoglobulin G levels we ob-
served in our study are indicative of subclinical reactivation.
Further research incorporating herpesvirus DNA samples is
needed.
Although psychosocial stress has generally been associ-
ated with subclinical reactivation of latent HSV-1 and CMV
(24, 59, 60), we were not able to address whether psycho-
social risk factors were predictive of antibody levels in this
study. Further research is required to assess whether meas-
ures of psychosocial stress mediate the relation between
educational attainment and herpesvirus antibody levels.
Other factors often associated with reactivation and mani-
festation of clinical disease include trauma such as organ
transplant, immunodeficiency, and exposure to ultraviolet
light for HSV-1 (61–64).
Aging is often accompanied by a decline in cell-mediated
(Th1) immune response. The cellular arm of the immune
response is responsible for maintaining latency of herpesvi-
ruses (24). Therefore, it is possible that the social gradient
we observed in response to these latent infections may be
observable only at older ages, during a period of immuno-
senescence. The effects of income were not as strong as
education in our study population. Although education
and income are typically highly correlated, educational level
commonly predicts health outcomes better at older ages,
when current retirement income may less accurately mea-
sure true economic resources compared with a more stable
marker such as education (65). A recent study by Evans
et al. (66) described a social gradient in secretory immuno-
globulin A in younger age groups. Further studies are re-
quired to assess whether the associations we observed exist
in younger populations.
This study identified a social gradient in immune re-
sponse to HSV-1 and CMV. Our results provide suggestive
evidence that modulation of the immune system via persis-
tent infections may play a role in the observed associations
between socioeconomic position and disease. Research on
the reactivation of herpesviruses is among the strongest and
most consistent experimental evidence of a relation between
stress and the immune system (22), suggesting that stress
may have played a role in our results. Other possibilities
cannot be excluded however, such as the likelihood that
individuals of lower socioeconomic position have higher
antibody levels because of a lifelong burden of exposure
to these infections. Further research is needed to clarify
the associations between socioeconomic position, stress,
immune response, and disease.
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